right-img

Home Featured News Finance News Banking News

finaceandbankingnewsnow

Home | Roche to buy US biotech firm InterMune

Roche to buy US biotech firm InterMune

August 25, 2014
SWISS pharmaceutical giant Roche says it will buy US-based lung disease treatment developer InterMune in a deal worth $US8.3 billion.
Read more at:http://news.com.au.feedsportal.com/c/34564/f/632570/s/3dce6302/sc/25/l/0L0Snews0N0Bau0Cfinance0Cbusiness0Croche0Eto0Ebuy0Eus0Ebiotech0Efirm0Eintermune0Cstory0Ee6frfkur0E12270A352832870Dfrom0Fpublic0Irss/story01.htm

Other News

Site Created by finaceandbankingnewsnow.com